Back to 
HHLR ADVISORS, LTD.
HHLR ADVISORS, LTD.
KNSA
Showing 0 of 23 quarters
Position history for HHLR ADVISORS, LTD.'s holdings in KINIKSA PHARMACEUTICALS-A
As of its Q1 2024 13F, HHLR Advisors held 3,135,735 shares of KNSA (Kiniksa Pharmaceuticals), worth $61.9M. KNSA was 1.3% of HHLR Advisors' reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.